As we step into 2025, HydRegen is poised for a transformative year, building upon our commitment to revolutionise chemical manufacturing through sustainable and efficient biotechnologies.  

Hydrogenation, a fundamental chemical process with broad applications across petrochemicals, pharmaceuticals, and food production has traditionally relied on batch reactors. While effective for small-scale production and when multiple different products are required, rising production demands and tighter regulations on energy consumption and emissions are shifting the chemical industry towards advanced autoclave solutions to enhance their hydrogenation processes.  

I am proud my team's extraordinary achievements this year. Their dedication, innovative thinking, and collaborative attitudes have allowed us to surpass our goals and set new standards of excellence. Each team member's unique and invaluable contributions have been the cornerstone of our success. I am incredibly grateful to lead such a talented and committed group of individuals whose hard work and enthusiasm makes every challenge an opportunity, and every success a shared victory. 

2024 has been a year of breakthroughs for our Chemistry Team, which showcases our unwavering pursuit of innovation. As a team, we are advancing our technologies and  scaling-up our processes, paving the way to transforming sustainable chemistry. The team's collaborative spirit has been the driving force behind our success, and I couldn't be prouder of what we have achieved together.

The pharmaceuticals landscape is changing, in a positive way, and there is a growing appetite from both business and regulators for new technology and processes that can bring cost and sustainability savings. 

We've spent the summer working on

• commercially competitive Bio2Amine processes,

• showcasing our tech running routinley in higher TRL reactors, and

• demonstrating a 18-fold improvement in enzyme manufacturing increasing our cost-competitivity across the chemicals sector!

HydRegen’s Bio2Amine technology delivers sustainable, cost-efficient and safe chemical manufacturing with the power of biology: underpinning science published in Nature Communications.

HydRegen successfully completes tech transfer to Almac Sciences as part of the joint development project of its proprietary enzyme platform.